Medtronic, Inc. (MDT) Tops Q2 EPS by 2c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $91.27 +0.76%
Revenue Growth %: +11.0%
Financial Fact:
Net earnings: 977M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Revenue Growth %: +11.0%
Financial Fact:
Net earnings: 977M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q2 EPS of $0.84, $0.02 better than the analyst estimate of $0.82. Revenue for the quarter came in at $4.13 billion versus the consensus estimate of $4.07 billion.
Medtronic, Inc. reaffirmed FY2011 guidance.
Medtronic, Inc. reaffirmed FY2011 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
